News

The U.S. Food and Drug Administration announced Aug. 8 its approval of Lucentis (ranibizumab injection) for the treatment of diabetic macular edema, an eye condition in people with diabetes that causes blurred vision, severe vision loss and sometimes blindness. Research and advocacy from two Weill Cornell Medical College leaders contributed to the FDA's approval.

Internal medicine residents honored at annual banquet plus additional awards, honors, prizes and achievements for the week of Aug. 10 - Aug. 17.

Tiny space age probes -- those that can see inside single living cells -- are increasingly being used to diagnose illness in hard-to-reach areas of the body.

Your body is a reflection of your health, and every day it sends out signals about how healthy or unhealthy you may be. If you can read the signs correctly, you will be better equipped to detect and prevent the onset of illness.

Two researchers at Weill Cornell Medical College have deciphered a mouse's retina's neural code and coupled this information to a novel prosthetic device to restore sight to blind mice. The researchers say they have also cracked the code for a monkey retina -- which is essentially identical to that of a human -- and hope to quickly design and test a device that blind humans can use.

A pioneer in reproductive endocrinology, Dr. Brij B. Saxena, the Harold and Percy Uris Professor of Reproductive Biology and professor of endocrinology in the Department of Obstetrics and Gynecology at Weill Cornell Medical College, passed away on July 30. Dr. Saxena, who joined the Medical College faculty in 1966, dedicated more than 45 years of service to Weill Cornell and discovery research.

Dr. Laurie H. Glimcher speaks with Dr. Mark Lachs, co-chief of the Division of Geriatric Medicine, who is particularly interested in ending elder abuse and promoting healthy aging.

Awards, honors, prizes and achievements for the week of Aug. 3 - Aug. 10.

Researchers have successfully developed and tested a new prostate cancer screening method that uses the combined power of a novel drug therapy and changes in PSA levels over time to identify men with a high PSA who are more likely to have aggressive prostate cancer despite negative biopsies.

The research enterprise at the CornellNYC Tech campus has taken a major step forward, with key stakeholders beginning to shape the school's focus on fostering technologies to promote a healthier life.

Awards, honors, prizes and achievements for the week of July 27 - Aug. 3.

A monthly highlight of grants obtained by Weill Cornell Medical College researchers, clinicians and students.

Weill Cornell Medical College has received $49.6 million from the National Center for Advancing Translational Sciences (NCATS), of the National Institutes of Health (NIH), to fund its Clinical and Translational Science Center (CTSC). This Clinical and Translational Science Award (CTSA) is a 5-year renewal of the largest Federal grant ever awarded to the Medical College by the NIH. In 2007, the first CTSA grant award supported the establishment of Weill Cornell's CTSC, a multi-institutional consortium in New York City with the goal of accelerating new patient preventive interventions and treatments through translational research.

As a man's waistline grows, so can his experience with sexual dysfunction and frequent urination, say researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The study, published in the August issue of the British Journal of Urology International (BJUI), is the first to comprehensively show that obesity in men affects not just their hearts and metabolism, but also their sexual and urinary health.

Dr. Laurie H. Glimcher speaks with Dr. Barbara Hempstead, a physician-scientist who just a few months ago was appointed associate dean for the newly-created Office of Faculty Development.

Dr. Laurie H. Glimcher appeared live on CNBC Wednesday morning to weigh in on health care reform and the importance of biomedical research in enhancing human health.

Awards, honors, prizes and achievements for the week of July 20 - July 27.

It was just a little more than a year ago when cameras began following Weill Cornell Medical College faculty and their patients at NewYork-Presbyterian Hospital/Weill Cornell Medical Center to view the world of medicine through a raw, real and intimate lens.

Standing before the faculty of the Department of Genetic Medicine at Weill Cornell Medical College, three Qatari high school students outlined all they had accomplished over the last two weeks: differentiating cell types, culturing cell lines, performing a DNA restriction digest and transfecting cells with a reporter gene -- among a half-dozen other scientific and laboratory techniques.